The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Trasylol (aprotinin), manufactured by Bayer, is a medication used to treat excessive bleeding and inflammation in patients undergoing coronary artery bypass grafting surgery (CABG). Due to nature of CABG procedures, most people do not realize they received the drug until after the surgery is over, if ever. That practice however is slowly changing as the FDA and the New England Journal of Medicine have recently linked Trasylol to renal failure, heart attacks, and strokes. For those who have endured the CABG procedure, and subsequently suffered from a heart attack, stroke, and/or renal failure, these findings may come as a complete shock to the unwary patient. To understand more about the effects of Trasylol contact one of personal injury attorneys.

Comments are closed.

Of Interest